{"id":"NCT01243944","sponsor":"Incyte Corporation","briefTitle":"Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)","officialTitle":"Randomized, Open Label, Multicenter Phase III Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 Tablets Versus Best Available Care (The RESPONSE Trial)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10-27","primaryCompletion":"2014-01-15","completion":"2018-02-09","firstPosted":"2010-11-19","resultsPosted":"2015-03-06","lastUpdate":"2019-03-06"},"enrollment":222,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Polycythemia Vera"],"interventions":[{"type":"DRUG","name":"ruxolitinib tablets","otherNames":[]},{"type":"OTHER","name":"Best Available Therapy (BAT)","otherNames":["BAT could include:","Hydroxyurea","IFN/PEG-IFN","Pipobroman","Anagrelide","Lenalidomide","Pomalidomide","Observation only"]}],"arms":[{"label":"ruxolitinib tablets","type":"EXPERIMENTAL"},{"label":"Best Available Therapy","type":"OTHER"}],"summary":"This pivotal phase III trial (CINC424B2301) is designed to compare the efficacy and safety of ruxolitinib (INC424) to Best Available Therapy (BAT) in participants with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea (HU).","primaryOutcome":{"measure":"The Percentage of Participants Achieving a Primary Response at Week 32","timeFrame":"32 Weeks","effectByArm":[{"arm":"Ruxolitinib","deltaMin":22.7,"sd":null},{"arm":"Best Available Therapy","deltaMin":0.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":102,"countries":["United States","Argentina","Australia","Belgium","Canada","China","France","Germany","Hungary","Italy","Japan","Netherlands","Russia","South Korea","Spain","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["31982039","29396713","28193568","27102499","25629741"],"seeAlso":["http://responsetrial.com"]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":110},"commonTop":["Pruritus","Headache","Anaemia","Fatigue","Diarrhoea"]}}